Detalles de la búsqueda
1.
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
Oncologist
; 29(3): 254-262, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262444
2.
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial.
Oncologist
; 28(10): 894-900, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315114
3.
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated With Axitinib: Subgroup Analysis from TIVO-3.
Oncologist
; 28(3): e167-e170, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36576430
4.
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE).
Future Oncol
; 18(40): 4465-4471, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36912078
5.
Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
Future Oncol
; 17(18): 2339-2350, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709776
6.
Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer.
Clin Genitourin Cancer
; 20(6): 553-557, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096984
7.
Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy.
Adv Ther
; 38(5): 2644-2661, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33866526
8.
Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysis.
J Manag Care Spec Pharm
; 27(9): 1171-1181, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165322
9.
Efficacy and immune-related adverse event associations in avelumab-treated patients.
J Immunother Cancer
; 8(2)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219092
10.
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program.
J Immunother Cancer
; 8(1)2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32269140
11.
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 7(1): 12, 2019 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30651126
12.
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial.
J Immunother Cancer
; 6(1): 111, 2018 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348224
Resultados
1 -
12
de 12
1
Próxima >
>>